FEDERATED HERMES, INC. - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 110 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,041
-98.4%
925
-98.6%
0.00%
-100.0%
Q1 2023$320,420
-48.5%
63,956
-49.9%
0.00%
-50.0%
Q4 2022$622,371
-78.0%
127,535
+36.3%
0.00%
-60.0%
Q1 2021$2,830,000
+158.0%
93,597
+322.5%
0.01%
+150.0%
Q4 2020$1,097,000
-73.8%
22,152
-79.7%
0.00%
-80.0%
Q3 2020$4,190,000
+9.2%
109,152
+22.9%
0.01%
+11.1%
Q2 2020$3,837,00088,8080.01%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$2,271,0002.63%
Sofinnova Investments, Inc. 2,194,278$26,068,0001.98%
MPM BioImpact LLC 443,702$5,271,0001.42%
Soleus Capital Management, L.P. 238,982$2,839,0000.37%
Lombard Odier Asset Management (Switzerland) SA 221,774$2,635,0000.21%
Artal Group S.A. 400,000$4,752,0000.20%
Polar Capital Holdings Plc 2,877,671$34,187,0000.15%
ASHFORD CAPITAL MANAGEMENT INC 106,770$1,268,0000.14%
Cormorant Asset Management, LP 150,000$1,782,0000.14%
Virtus ETF Advisers LLC 23,646$281,0000.13%
View complete list of Y-MABS THERAPEUTICS INC shareholders